Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

50%

5 of 10 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

N/A

5(50.0%)

Phase 2

3(30.0%)

Phase 3

2(20.0%)

10Total

N/A(5)

Phase 2(3)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT03981822Phase 2Completed

A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts

Role: collaborator

NCT03487549Phase 2Completed

Cantharidin and Occlusion in Verruca Epithelium

Role: collaborator

NCT04671576Not ApplicableCompleted

Growth and Safety Clinical Trial on a New Infant Formula.

Role: collaborator

NCT03377790Phase 3Completed

Cantharidin Application in Molluscum Patients-1

Role: collaborator

NCT03377803Phase 3Completed

Cantharidin Application in Molluscum Patients

Role: collaborator

NCT04593147Not ApplicableCompleted

Phase II Growth and Safety Study of an Infant Formula for Healthy Term Infants

Role: collaborator

NCT03186378Phase 2Completed

Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.

Role: collaborator

NCT04389606Not ApplicableCompleted

Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants

Role: collaborator

NCT04218929Not ApplicableCompleted

Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants

Role: collaborator

NCT03331276Not ApplicableCompleted

Growth and Safety Study of an Infant Formula for Healthy Term Infants

Role: collaborator

All 10 trials loaded